GlassScriptPhysician profile
Matthew B Martin
NPI 1396729018
$15,613.58
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $469 · 2020: $128 · 2021: $191 · 2022: $14K · 2023: $337 · 2024: $698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,392.74 | 2022-2024 | |
| Medtronic, INC. | $778.10 | 2021-2024 | Signia, Ligasure, Emprint |
| Ethicon US, LLC | $258.38 | 2019-2024 | Enseal |
| Reshape Lifesciences INC. | $186.01 | 2022-2023 | |
| Covidien LP | $179.70 | 2019 | |
| Stryker Corporation | $122.29 | 2022-2024 | 1788 |
| Heron Therapeutics, INC. | $94.06 | 2022-2024 | Zynrelef |
| Merck Sharp & Dohme LLC | $72.92 | 2020-2023 | Keytruda |
| Medical Device Business Services, INC. | $58.05 | 2024 | Echelon Flex |
| Takeda Pharmaceuticals U.S.A., INC. | $52.06 | 2021 | |
| Teleflex LLC | $50.92 | 2024 | Titan Sgs |
| Wound Management Technologies, INC | $46.15 | 2019 | |
| Smith+Nephew, INC. | $44.40 | 2020-2022 | |
| Innocoll Pharmaceuticals Limited | $40.32 | 2021-2022 | |
| Kerecis Limited | $35.83 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $30.83 | 2020 | |
| Endo Pharmaceuticals INC. | $30.57 | 2019 | |
| Baxter Healthcare | $26.38 | 2019 | |
| Shire North American Group INC | $25.82 | 2019 | |
| Rti Surgical, INC | $24.86 | 2023 | |
| Csl Behring | $18.55 | 2019 | |
| Abbvie INC. | $17.40 | 2020 | |
| Tei Biosciences INC | $14.96 | 2019 | |
| Bioptics, INC. | $12.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.